SERPINE1/PAI-1 emerges as a key regulator of inflammation-coagulation-fibrinolysis crosstalk in ARDS
Background
Acute respiratory distress syndrome (ARDS) is a severe form of hypoxic respiratory failure, characterized by dysregulated pulmonary inflammation. Current standard-of-care often falls short due to the syndrome's heterogeneity and the complex interplay of inflammation, coagulation, and fibrinolysis. A key gap exists in identifying integrative regulators that could serve as both biomarkers and therapeutic targets. SERPINE1, also known as plasminogen activator inhibitor-1 (PAI-1), is a critical component of the fibrinolytic system, and its dysregulation is increasingly recognized in inflammatory and thrombotic disorders, making it a compelling candidate for study in ARDS pathobiology.
Study Design
This narrative review systematically synthesized current evidence on the role of SERPINE1/PAI-1 in acute respiratory distress syndrome (ARDS). Researchers gathered and summarized published experimental, translational, genetic, and clinical studies addressing SERPINE1/PAI-1 in ARDS and related critical illnesses. The review focused on elucidating pathobiological functions, cellular sources, biomarker potential, genetic associations, and therapeutic implications of SERPINE1/PAI-1 within inflammation-coagulation-fibrinolysis crosstalk. This comprehensive approach aimed to integrate diverse findings for a holistic understanding of SERPINE1's impact.
Results
The review conclusively established that SERPINE1 significantly limits tissue-type and urokinase-type plasminogen activator activity, leading to hypofibrinolysis and persistent fibrin deposition within the injured lung in ARDS. This dysregulation contributes directly to greater disease severity and adverse patient outcomes. Furthermore, the synthesis highlighted that high-expression SERPINE1 genetic variants may influence clinical trajectories and outcomes in specific critical illness settings, underscoring a genetic predisposition component. While pharmacological PAI-1 inhibition shows biological plausibility as a therapeutic strategy, its translation into effective ARDS treatment is currently hampered by the inherent heterogeneity of the disease, uncertainties regarding optimal treatment timing, and the significant risk of bleeding complications. The evidence suggests SERPINE1 is a potent, integrative regulator of the complex interplay between inflammation, coagulation, and fibrinolysis in ARDS.
Key Findings
- SERPINE1/PAI-1 limits plasminogen activator activity, promoting
hypofibrinolysisand fibrin deposition in injured lungs. - Elevated PAI-1 is linked to inflammatory amplification, endothelial injury, and pulmonary microvascular thrombosis in ARDS.
- High PAI-1 levels correlate with increased ARDS disease severity and adverse patient outcomes.
- Genetic variants of
SERPINE1associated with high expression may influence clinical outcomes in critical illness. - Pharmacological
PAI-1inhibition is biologically plausible but faces challenges in clinical translation due to ARDS heterogeneity and bleeding risk.
Why It Matters
Understanding SERPINE1/PAI-1 as an integrative regulator in ARDS offers a crucial paradigm shift, moving beyond single-pathway interventions to address the complex interplay of inflammation, coagulation, and fibrinolysis simultaneously. This insight opens new avenues for developing targeted therapeutic strategies and identifying novel biomarkers for ARDS severity and prognosis. For clinicians, monitoring PAI-1 levels could potentially refine risk stratification and guide personalized treatment approaches, although this requires further validation. The prospect of pharmacological PAI-1 inhibition, while promising, necessitates extensive research to overcome challenges like disease heterogeneity and the delicate balance between preventing thrombosis and inducing bleeding. Future protocols might involve PAI-1 modulation, but this is far from a usable clinical protocol today, requiring clarification of causal, cell-specific, and phenotype-dependent roles to ensure safe and effective translation.
serpine1
pai-1
ards
inflammation
coagulation
fibrinolysis